Overview

Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This is a study to determine the response rate in patients with myelodysplastic syndromes treated with calcitriol and dexamethasone.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Treatments:
BB 1101
Calcitriol
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate